PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 • PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY TYPE • Market segmentation by type • Comparison by type • Powder and liquid - Market size and forecast 2018-2023 • Depot - Market size and forecast 2018-2023 • Market opportunity by type PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges • PART 11: MARKET TRENDS • Technological advancements in jet injector devices • Business strategies • Increasing focus on the development of biologics PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive scenario PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Antares Pharma, Inc. • Beijing Kushur Medical Technology Co. Ltd. • Crossject • Endo International Plc • European Pharma Group BV • INJEX Pharma GmbH • Inovio Pharmaceuticals Inc. • Medical International Technologies Inc. • National Medical Products Inc. • PharmaJet Inc. PART 14: APPENDIX • Research methodology • List of abbreviations • Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Product overview Exhibit 02: Global medical devices market Exhibit 03: Segments of global medical devices market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: Type - Market share 2018-2023 (%) Exhibit 19: Comparison by type Exhibit 20: Powder and liquid - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Powder and liquid - Year-over-year growth 2019-2023 (%) Exhibit 22: Depot - Market size and forecast 2018-2023 ($ millions) Exhibit 23: Depot - Year-over-year growth 2019-2023 (%) Exhibit 24: Market opportunity by type Exhibit 25: Customer landscape Exhibit 26: Market share by geography 2018-2023 (%) Exhibit 27: Geographic comparison Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 29: Number of cases of infectious diseases in 2016 in the US Exhibit 30: Rate of vaccination coverage among the population aged 19 to 35 months in 2016 in US Exhibit 31: North America - Year-over-year growth 2019-2023 (%) Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 33: Geriatric population aged 65 years and above (2016 & 2018) in Europe Exhibit 34: Europe - Year-over-year growth 2019-2023 (%) Exhibit 35: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 36: Asia - Year-over-year growth 2019-2023 (%) Exhibit 37: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 38: ROW - Year-over-year growth 2019-2023 (%) Exhibit 39: Key leading countries Exhibit 40: Market opportunity Exhibit 41: Impact of drivers and challenges Exhibit 42: Vendor landscape Exhibit 43: Landscape disruption Exhibit 44: Vendors covered Exhibit 45: Vendor classification Exhibit 46: Market positioning of vendors Exhibit 47: Antares Pharma Inc. - Vendor overview Exhibit 48: Antares Pharma Inc. - Organizational developments Exhibit 49: Antares Pharma Inc. - Geographic focus Exhibit 50: Antares Pharma Inc. - Key offerings Exhibit 51: Antares Pharma Inc. - Key customers Exhibit 52: Beijing Kushur Medical Technology Co. Ltd. - Vendor overview Exhibit 53: Beijing Kushur Medical Technology Co. Ltd. - Key offerings Exhibit 54: Beijing Kushur Medical Technology Co. Ltd. - Key customers Exhibit 55: Crossject - Vendor overview Exhibit 56: Crossject - Organizational developments Exhibit 57: Crossject - Key offerings Exhibit 58: Crossject - Key customers Exhibit 59: Endo International Plc - Vendor overview Exhibit 60: Endo International Plc - Business segments Exhibit 61: Endo International Plc - Organizational developments Exhibit 62: Endo International Plc - Segment focus Exhibit 63: Endo International Plc - Key offerings Exhibit 64: Endo International Plc - Key customers Exhibit 65: European Pharma Group BV - Vendor overview Exhibit 66: European Pharma Group BV - Key offerings Exhibit 67: European Pharma Group BV - Key customers Exhibit 68: INJEX Pharma GmbH - Vendor overview Exhibit 69: INJEX Pharma GmbH - Product segments Exhibit 70: INJEX Pharma GmbH - Key offerings Exhibit 71: INJEX Pharma GmbH - Key customers Exhibit 72: Inovio Pharmaceuticals Inc. - Vendor overview Exhibit 73: Inovio Pharmaceuticals Inc. - Organizational developments Exhibit 74: Inovio Pharmaceuticals Inc. - Key offerings Exhibit 75: Inovio Pharmaceuticals Inc. - Key customers Exhibit 76: Medical International Technologies Inc. - Vendor overview Exhibit 77: Medical International Technologies Inc. - Product segments Exhibit 78: Medical International Technologies Inc. - Key offerings Exhibit 79: Medical International Technologies Inc. - Key customers Exhibit 80: National Medical Products Inc. - Vendor overview Exhibit 81: National Medical Products Inc. - Key offerings Exhibit 82: National Medical Products Inc. - Key customers Exhibit 83: PharmaJet Inc. - Vendor overview Exhibit 84: PharmaJet Inc. - Organizational developments Exhibit 85: PharmaJet Inc. - Key offerings Exhibit 86: PharmaJet Inc. - Key customers Exhibit 87: Validation techniques employed for market sizing Exhibit 88: Definition of market positioning of vendors

Antares Pharma Inc., Beijing Kushur Medical Technology Co. Ltd., Crossject, Endo International Plc, European Pharma Group BV, INJEX Pharma GmbH, Inovio Pharmaceuticals Inc., Medical International Technologies Inc., National Medical Products Inc., and PharmaJet Inc.